Precipio Inc (PRPO) FinancialsPRPOFinancialPrecipio Inc

Precipio Inc (PRPO) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Third party payers, accounting for 47.7% of total sales, equivalent to $2.69M. Other significant revenue streams include Medicare and Other. Understanding this composition is critical for investors evaluating how PRPO navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Precipio Inc maintains a gross margin of 75.40%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 48.80%, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively PRPO converts its operational activities into shareholder value.

In the context of the broader market, PRPO competes directly with industry leaders such as EUDA and DCGO. With a market capitalization of $51.65M, it holds a leading position in the sector. When comparing efficiency, PRPO's gross margin of 75.40% stands against EUDA's 43.77% and DCGO's 26.85%. Such benchmarking helps identify whether Precipio Inc is trading at a premium or discount relative to its financial performance.

Precipio has demonstrated robust revenue growth, with Q2 2026 revenue at over $7 million, reflecting a 22% year-over-year increase. The gross margin has also significantly improved to 75.4%, indicating better cost management and profitability potential.